Loading stock data…
$47.80-1.66 (-3.36%)
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Prestige Consumer Healthcare Inc. in the Healthcare sector is trading at $47.80 with a market capitalization of $2.2B. Wall Street consensus targets $67.80 (5 analysts), implying a +41.8% move over the next 12 months. The stock is currently near its 52-week low of $42.62, remaining 12.3% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $265.71M↓ | $281.62M↓ | $283.44M↑ | $274.11M↑ | $249.53M |
| Gross Profit | $136.19M↓ | $146.30M↓ | $157.37M↑ | $151.58M↑ | $140.33M |
| Operating Income | $52.52M↓ | $75.49M↓ | $82.49M↑ | $79.67M↑ | $71.76M |
| Net Income | $29.18M↓ | $53.93M↑ | $46.70M↑ | $42.21M↓ | $47.47M |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two s...